# Taurine Therapy for SSADH Deficiency

> **NCT01608178** · — · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 7 (actual)

## Conditions studied

- Succinic Semialdehyde Dehydrogenase

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01608178
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-27
- **Primary completion:** —
- **Final completion:** 2013-12-16
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01608178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01608178, "Taurine Therapy for SSADH Deficiency". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01608178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*